Obtinib Tablet is a domestically produced drug, which is a tyrosine kinase inhibitor and belongs to a type of oral chemotherapy prescription drug for adults. Obtinib tablets are mainly used for the treatment of adult small lymphocytic lymphoma, chronic lymphocytic leukemia, set cell lymphoma that have been previously treated with at least one therapy. As this product belongs to the chemotherapy prescription drug, random must be used under the guidance of professional doctors, patients should not arbitrarily adjust the dose and so on. Obtinib Tablets should be swallowed whole with water, not chewed or broken. During the administration of Obtinib Tablets, patients are advised to consult a doctor in time if any adverse reaction occurs. The common adverse reactions of Obtinib Tablet mainly include cardiac arrhythmia, hematuria, purpura and so on. Those who are allergic to Obtinib and those with severe hepatic insufficiency need to disable this product.